Elizabeth Rozycki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Rozycki has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Craig Cocchio
Department of Pharmacy CHRISTUS Trinity Mother Frances Health System Tyler Texas USA
2 shared publications- Kyle A. Weant
University of South Carolina College of Pharmacy Columbia South Carolina USA
2 shared publications Marc Sturgill
Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey Piscataway New Jersey USA
2 shared publicationsMary Beth Shirk
The Ohio State University College of Pharmacy, 500 W. 12th Ave 217 Parks Hall, Columbus, OH 43210, United States of America
2 shared publications- Matthew H. Bilhimer
Department of Pharmacy Olathe Medical Center Olathe Kansas USA
2 shared publications Meghan Groth
Medical Science Liaison Glaxo Smith Kline Pharmaceuticals Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Wiley in Academic Emergency Medicine
- Vol. 33 (3) , e70257
Evaluation of Potentially Inappropriate Medications Prescribed to Older Adults Upon Emergency Department Discharge
Background: Older adults are susceptible to adverse drug effects due to age‐related changes, a higher prevalence of comorbidities, and complexities in medication management. Nearly half of geriatric patients are prescribed at least one new medication at ED discharge. This study evaluated potential pharmacist interventions on ED discharge prescriptions for older adults using the Geriatric Emergency Medicine Safety Recommendations (GEMS‐Rx) list. Methods: This single‐center, IRB‐approved, retrospective review analyzed ED discharge prescriptions for potentially inappropriate medications based on GEMS‐Rx criteria from October 2021 to September 2024 for patients ≥ 65 years who were discharged from the ED. Prescriptions were reviewed by a trained pharmacist for medication‐related problems (MRPs). Outcomes included: rate of potential pharmacist intervention, number of prescriptions with at least one MRP, MRP types, missing risk vs. benefit documentation, rates of current practice pharmacist review, two or more GEMS‐Rx prescriptions at discharge, and polypharmacy. All prescriptions during the study period were reviewed to determine medication sub‐class distribution, with a random sample of 250 patients, ensuring at least 10 prescriptions per sub‐class, if available. Descriptive statistics were utilized. Results: During the study period, 1458 prescriptions were written for included sub‐classes. Of 284 prescriptions screened, 265 (for 250 patients) were included. The median (IQR) age was 69.5 (67–75) years with patients on a median (IQR) of 5 (3–8) scheduled home medications and discharged with a median (IQR) of 2 (1–3) new medications. Skeletal muscle relaxants (37.0%) and first‐generation antihistamines (28.7%) were most frequent. Pharmacist intervention was potentially needed in 204 patients (81.6.%) with a median (IQR) of 2 (1, 2) MRPs per patient. Common MRPs included dose adjustment (53.2%), indication mismatch (41.1%), and frequency (38.1%). Conclusions: Most GEMS‐Rx prescriptions had at least one MRP, indicating an opportunity for enhanced prescribing. Future research should target strategies to optimize medications at ED discharge for older adults.
- 9 March 2026
- Published by Wiley in Academic Emergency Medicine
- Vol. 33 (3) , e70257
Open AccessEvaluation of Potentially Inappropriate Medications Prescribed to Older Adults Upon Emergency Department Discharge
Background: Older adults are susceptible to adverse drug effects due to age‐related changes, a higher prevalence of comorbidities, and complexities in medication management. Nearly half of geriatric patients are prescribed at least one new medication at ED discharge. This study evaluated potential pharmacist interventions on ED discharge prescriptions for older adults using the Geriatric Emergency Medicine Safety Recommendations (GEMS‐Rx) list. Methods: This single‐center, IRB‐approved, retrospective review analyzed ED discharge prescriptions for potentially inappropriate medications based on GEMS‐Rx criteria from October 2021 to September 2024 for patients ≥ 65 years who were discharged from the ED. Prescriptions were reviewed by a trained pharmacist for medication‐related problems (MRPs). Outcomes included: rate of potential pharmacist intervention, number of prescriptions with at least one MRP, MRP types, missing risk vs. benefit documentation, rates of current practice pharmacist review, two or more GEMS‐Rx prescriptions at discharge, and polypharmacy. All prescriptions during the study period were reviewed to determine medication sub‐class distribution, with a random sample of 250 patients, ensuring at least 10 prescriptions per sub‐class, if available. Descriptive statistics were utilized. Results: During the study period, 1458 prescriptions were written for included sub‐classes. Of 284 prescriptions screened, 265 (for 250 patients) were included. The median (IQR) age was 69.5 (67–75) years with patients on a median (IQR) of 5 (3–8) scheduled home medications and discharged with a median (IQR) of 2 (1–3) new medications. Skeletal muscle relaxants (37.0%) and first‐generation antihistamines (28.7%) were most frequent. Pharmacist intervention was potentially needed in 204 patients (81.6.%) with a median (IQR) of 2 (1, 2) MRPs per patient. Common MRPs included dose adjustment (53.2%), indication mismatch (41.1%), and frequency (38.1%). Conclusions: Most GEMS‐Rx prescriptions had at least one MRP, indicating an opportunity for enhanced prescribing. Future research should target strategies to optimize medications at ED discharge for older adults.
- Open Access
- 3 October 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e246
Integrating an antimicrobial stewardship bundle into advanced urgent care sites
Objective: Urgent care locations remain a target for antimicrobial stewardship initiatives due to high rates of inappropriate antibiotic prescribing, particularly for respiratory tract infections. This study evaluated the impact of an antimicrobial stewardship bundle at urgent care sites on appropriate antibiotic prescriptions. Design: Retrospective, observational, pre- and post-analysis. Setting: Four advanced urgent care sites affiliated with an academic medical institution. Patients: Urgent care patients evaluated for respiratory tract infections. Intervention: An antimicrobial stewardship bundle including clinician-signed stewardship posters, over-the-counter medication prescription pads, and an educational campaign was introduced to advanced urgent care sites from October to November 2024. Respiratory tract infections were tiered by antibiotic appropriateness (1 = always appropriate; 2 = sometimes appropriate; 3 = never appropriate). Adults with tier 2 or 3 diagnoses from December 2023 to January 2024 (pre-group) and December 2024 to January 2025 (post-group) were included. The primary outcome was proportion of appropriate antibiotic prescriptions. Results: Two hundred and seventy-five patients with tier 2 and tier 3 indications were screened; 200 patients were included. Following implementation of the antimicrobial stewardship bundle, there was no significant difference in rates of appropriate antibiotic prescriptions for tier 2 and tier 3 respiratory infections between the pre- and post-groups (76% vs 74%, respectively; P = 0.68). After implementation, more patients received appropriate antibiotics for tier 2 indications (77% vs 95%; p = 0.13). The most prescribed antibiotic agents amongst both groups were amoxicillin-based antibiotics (15%) and azithromycin (15%). Conclusion: This study highlights challenges and opportunities for outpatient antimicrobial stewardship practices.
- 3 October 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e246
Open AccessIntegrating an antimicrobial stewardship bundle into advanced urgent care sites
Objective: Urgent care locations remain a target for antimicrobial stewardship initiatives due to high rates of inappropriate antibiotic prescribing, particularly for respiratory tract infections. This study evaluated the impact of an antimicrobial stewardship bundle at urgent care sites on appropriate antibiotic prescriptions. Design: Retrospective, observational, pre- and post-analysis. Setting: Four advanced urgent care sites affiliated with an academic medical institution. Patients: Urgent care patients evaluated for respiratory tract infections. Intervention: An antimicrobial stewardship bundle including clinician-signed stewardship posters, over-the-counter medication prescription pads, and an educational campaign was introduced to advanced urgent care sites from October to November 2024. Respiratory tract infections were tiered by antibiotic appropriateness (1 = always appropriate; 2 = sometimes appropriate; 3 = never appropriate). Adults with tier 2 or 3 diagnoses from December 2023 to January 2024 (pre-group) and December 2024 to January 2025 (post-group) were included. The primary outcome was proportion of appropriate antibiotic prescriptions. Results: Two hundred and seventy-five patients with tier 2 and tier 3 indications were screened; 200 patients were included. Following implementation of the antimicrobial stewardship bundle, there was no significant difference in rates of appropriate antibiotic prescriptions for tier 2 and tier 3 respiratory infections between the pre- and post-groups (76% vs 74%, respectively; P = 0.68). After implementation, more patients received appropriate antibiotics for tier 2 indications (77% vs 95%; p = 0.13). The most prescribed antibiotic agents amongst both groups were amoxicillin-based antibiotics (15%) and azithromycin (15%). Conclusion: This study highlights challenges and opportunities for outpatient antimicrobial stewardship practices.
- 16 July 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 72, 101-106
Pharmacist involvement in blood culture follow up for patients discharged from the emergency department
- 16 July 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 72, 101-106
Pharmacist involvement in blood culture follow up for patients discharged from the emergency department
- 2 February 2022
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 57 (5) , 639-645
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department
Background: Patients presenting for emergency department (ED) evaluation may be appropriate for treatment with monoclonal antibodies for mild to moderate COVID-19. While many sites have implemented infusion centers for these agents, EDs will continue to evaluate these patients where appropriate identification and efficient infusion of eligible patients is critical. Objectives: Patients receiving bamlanivimab in the EDs of an academic medical center are described. The primary objective was to describe operational metrics and secondary objectives reported clinical outcomes. Methods: Patients receiving bamlanivimab and discharged from the ED were included from November 16, 2020 to January 16, 2021 in the retrospective, observational cohort. Primary outcome was adherence to institutional criteria. Secondary outcomes included ED visit metrics, clinical characteristics, and return visits within 30 days. Risk factors for return visits were assessed with regression. Results: One hundred nineteen patients were included. Most (71%) were diagnosed with COVID-19 during the ED visit and median symptom duration was 3(IQR 2-5) days. Median number of risk factors for progression to severe disease was 2 (IQR 1-2). Thirty percent had a documented abnormal chest x-ray. Institutional criteria adherence was 99.2%. Median time from ED room to bamlanivimab was 4 (IQR 3.1-5.2) hours. Thirty patients had return visit within 30 days; 19 were COVID-19 related. Two multivariable regression models were analyzed for COVID-19 related return visit. Characteristics on ED presentation were considered in Model I: male gender (OR 3.01[0.97-9.31]), age (per 10 years) (OR 1.49[1.05-2.12]), African-American race (OR 3.46[1.09-11.06]), and symptom duration (per day) (OR 1.34[1.05-1.73]). Model II included labs and imaging acquired in ED. In Model II, age (per 10 years) (OR 1.52[1.07-2.16]) and abnormal CXR (OR 5.74[1.95-16.9]) were associated with COVID-19 related return visits. Conclusions: Administration of bamlanivimab to ED patients can be done efficiently, with the potential to reduce COVID-19 related return visits. Age and abnormal imaging were independent predictors of COVID-19 return visits.
- 2 February 2022
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 57 (5) , 639-645
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department
Background: Patients presenting for emergency department (ED) evaluation may be appropriate for treatment with monoclonal antibodies for mild to moderate COVID-19. While many sites have implemented infusion centers for these agents, EDs will continue to evaluate these patients where appropriate identification and efficient infusion of eligible patients is critical. Objectives: Patients receiving bamlanivimab in the EDs of an academic medical center are described. The primary objective was to describe operational metrics and secondary objectives reported clinical outcomes. Methods: Patients receiving bamlanivimab and discharged from the ED were included from November 16, 2020 to January 16, 2021 in the retrospective, observational cohort. Primary outcome was adherence to institutional criteria. Secondary outcomes included ED visit metrics, clinical characteristics, and return visits within 30 days. Risk factors for return visits were assessed with regression. Results: One hundred nineteen patients were included. Most (71%) were diagnosed with COVID-19 during the ED visit and median symptom duration was 3(IQR 2-5) days. Median number of risk factors for progression to severe disease was 2 (IQR 1-2). Thirty percent had a documented abnormal chest x-ray. Institutional criteria adherence was 99.2%. Median time from ED room to bamlanivimab was 4 (IQR 3.1-5.2) hours. Thirty patients had return visit within 30 days; 19 were COVID-19 related. Two multivariable regression models were analyzed for COVID-19 related return visit. Characteristics on ED presentation were considered in Model I: male gender (OR 3.01[0.97-9.31]), age (per 10 years) (OR 1.49[1.05-2.12]), African-American race (OR 3.46[1.09-11.06]), and symptom duration (per day) (OR 1.34[1.05-1.73]). Model II included labs and imaging acquired in ED. In Model II, age (per 10 years) (OR 1.52[1.07-2.16]) and abnormal CXR (OR 5.74[1.95-16.9]) were associated with COVID-19 related return visits. Conclusions: Administration of bamlanivimab to ED patients can be done efficiently, with the potential to reduce COVID-19 related return visits. Age and abnormal imaging were independent predictors of COVID-19 return visits.
- 1 October 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 48, 288-294
Implementation of pharmacist targeted discharge prescription review in an emergency department
- 1 October 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 48, 288-294
Implementation of pharmacist targeted discharge prescription review in an emergency department
- 16 September 2020
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 3 (8) , 1423-1433
Evaluation of burnout among emergency medicine pharmacists
Introduction: Burnout syndrome is a prolonged response to chronic emotional and interpersonal stressors and is becoming an increasing concern in the medical community. Burnout in emergency medicine (EM) pharmacists has not been previously assessed.Objectives: To identify the prevalence of burnout among EM pharmacists, in addition to demographic, professional, seasonal, and job‐related associations.Methods: Pharmacists practicing greater than 50% of their time in the emergency department (ED) setting were invited through the American College of Clinical Pharmacy Emergency Medicine Practice and Research Network listserv to complete a survey at three separate, 4‐week, time periods (July 2018, October 2018, and April 2019). The survey contained the Maslach Burnout Inventory for Medical Personnel to detect burnout. Questions regarding personal and job‐specific demographics were asked. Descriptive statistics were used to report demographics and burnout dimensions in each period. Spearman's rank correlation and univariate and multivariate analyses were performed to identify predictors of burnout and potential associations.Results: A total of 485 surveys were completed across all periods (116 [July], 207 [October], 162 [April]) and response rates were 18.4%, 31.6%, and 22.7%, respectively. Burnout was identified in 69.8%, 67.1%, and 68.5% of respondents with no difference between periods. A majority of participants had high depersonalization scores (50.6‐76.3%) during the three survey periods.Younger age, more ED visits per year, level I trauma center designation, and lower percentage of direct patient care time were associated with increased odds of burnout in the July 2018 period. Intent to leave one's current position or the specialty of EM and consideration of a job with different hours had positive correlations with burnout.Conclusions: Burnout is prevalent in a majority of EM pharmacists throughout the year. It is difficult to identify exact predictors of burnout; however, potential contributors include age, trauma center designation, patient volumes, and direct patient care time.
- 16 September 2020
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 3 (8) , 1423-1433
Evaluation of burnout among emergency medicine pharmacists
Introduction: Burnout syndrome is a prolonged response to chronic emotional and interpersonal stressors and is becoming an increasing concern in the medical community. Burnout in emergency medicine (EM) pharmacists has not been previously assessed.Objectives: To identify the prevalence of burnout among EM pharmacists, in addition to demographic, professional, seasonal, and job‐related associations.Methods: Pharmacists practicing greater than 50% of their time in the emergency department (ED) setting were invited through the American College of Clinical Pharmacy Emergency Medicine Practice and Research Network listserv to complete a survey at three separate, 4‐week, time periods (July 2018, October 2018, and April 2019). The survey contained the Maslach Burnout Inventory for Medical Personnel to detect burnout. Questions regarding personal and job‐specific demographics were asked. Descriptive statistics were used to report demographics and burnout dimensions in each period. Spearman's rank correlation and univariate and multivariate analyses were performed to identify predictors of burnout and potential associations.Results: A total of 485 surveys were completed across all periods (116 [July], 207 [October], 162 [April]) and response rates were 18.4%, 31.6%, and 22.7%, respectively. Burnout was identified in 69.8%, 67.1%, and 68.5% of respondents with no difference between periods. A majority of participants had high depersonalization scores (50.6‐76.3%) during the three survey periods.Younger age, more ED visits per year, level I trauma center designation, and lower percentage of direct patient care time were associated with increased odds of burnout in the July 2018 period. Intent to leave one's current position or the specialty of EM and consideration of a job with different hours had positive correlations with burnout.Conclusions: Burnout is prevalent in a majority of EM pharmacists throughout the year. It is difficult to identify exact predictors of burnout; however, potential contributors include age, trauma center designation, patient volumes, and direct patient care time.
- 1 September 2020
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 3 (6) , 1048-1055
A cross-sectional survey of US hospital pharmacy leaders on departmental initiatives to address burnout
- 1 September 2020
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 3 (6) , 1048-1055
A cross-sectional survey of US hospital pharmacy leaders on departmental initiatives to address burnout
- Open Access
- 1 October 2017
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 70 (4) , S49
121 Association Between Systemic Inflammatory Response Syndrome Criteria and Bloodstream Infections in Immunosuppressed Patients in the Emergency Department
- 1 October 2017
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 70 (4) , S49
Open Access121 Association Between Systemic Inflammatory Response Syndrome Criteria and Bloodstream Infections in Immunosuppressed Patients in the Emergency Department